Who invested in METiS Therapeutics?
METiS Therapeutics's investors include HSG, 5Y Capital and FreeS Fund.
Who invested in METiS Therapeutics
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$75Mraised across 1 round since 2022, from 1 source
- Latest round
- Series B, $75MApr 2022
- Investors
- 3
The rounds
- Apr 2022
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about METiS Therapeutics
How much has METiS Therapeutics raised?
METiS Therapeutics has raised $75M across 1 round since 2022.
When did METiS Therapeutics last raise?
METiS Therapeutics's most recent round was a Series B of $75M in Apr 2022.
What was METiS Therapeutics's biggest round?
Its most recent round, $75M in Apr 2022, is also its largest on record.
Who backed METiS Therapeutics first?
METiS Therapeutics's first round on record, in Apr 2022, was backed by HSG, 5Y Capital and FreeS Fund.
What stage is METiS Therapeutics at?
METiS Therapeutics's latest named round is a Series B, in Apr 2022.
Companies like METiS Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.